ListedMainboardPharmaceuticals & DrugsSYMBIOTEC
Symbiotec Pharmalab IPO
Symbiotec Pharmalab IPO is a mainboard IPO raising ₹1,757 Cr at ₹938 – ₹988 a share. It listed on 1 Sept 2026 at ₹988, 0.0% against its issue price of ₹988, and trades at ₹1,230 today (+24.5% since issue). It was subscribed 71× in total.
₹988
Issue price
₹1,230
Price now
+24.5%
Since issue price
1 Sept 2026
Listed on
71×Subscribed (final) · all exchanges
71.3 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Lead managers, and how their past issues have done
Median return since issue price across every IPO we hold this bank on. Not a forecast for this issue — a record.
| Lead manager | IPOs we hold them on | Of which we can price | Median return since issue |
|---|---|---|---|
| JM Financial Limited | 117 | 107 | +15.5% |
| Avendus Capital Private Limited | 9 | 9 | +24.5% |
| Motilal Oswal Investment Advisors Limited | 54 | 52 | +12.3% |
| Nomura Financial Advisory | 27 | 24 | +29.1% |
| Securities (India) Private Limited | 27 | 24 | +31.0% |
A bank appears on an issue we can price only when the company is matched to our price history, so the two counts differ. See the full league table →
Registrar
Contact them about allotment, refunds or unblocking your application amount — not the company, and not the exchange.
NameMUFG Intime India Private Limited
ContactShanti Gopalkrishnan
Emailsymbiotecpharmalab.ipo@in.mpms.mufg.com
Phone+91 810 811 4949
Websitehttps://in.mpms.mufg.com/ ↗